
pmid: 32766157
pmc: PMC7378685
handle: 20.500.14243/384469 , 2108/408827 , 11586/465363 , 11571/1347795
pmid: 32766157
pmc: PMC7378685
handle: 20.500.14243/384469 , 2108/408827 , 11586/465363 , 11571/1347795
Molecular chaperones have recently emerged as fundamental regulators of salient biological routines, including metabolic adaptations to environmental changes. Yet, many of the molecular mechanisms at the basis of their functions are still unknown or at least uncertain. This is in part due to the lack of chemical tools that can interact with the chaperones to induce measurable functional perturbations. In this context, the use of small molecules as modulators of protein functions has proven relevant for the investigation of a number of biomolecular systems. Herein, we focus on the functions, interactions and signaling pathways of the HSP90 family of molecular chaperones as possible targets for the discovery of new molecular entities aimed at tuning their activity and interactions. HSP90 and its mitochondrial paralog, TRAP1, regulate the activity of crucial metabolic circuitries, making cells capable of efficiently using available energy sources, with relevant implications both in healthy conditions and in a variety of disease states and especially cancer. The design of small-molecules targeting the chaperone cycle of HSP90 and able to inhibit or stimulate the activity of the protein can provide opportunities to finely dissect their biochemical activities and to obtain lead compounds to develop novel, mechanism-based drugs.
570, Allosteric inhibitor, Anti-neoplastic strategie, chaperone proteins, Chaperone, Settore BIOS-07/A - Biochimica, TRAP1, chaperone, chaperones, HSP90, Tumor metabolism, RC254-282, Mitochondria; Tumor metabolism, allosteric inhibitor, HSP90 family, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, neoplastic progression, Mitochondria, mitochondria, Oncology, ATP-competitive inhibitors; HSP90; TRAP1; Allosteric inhibitor; Anti-neoplastic strategies; Chaperones;, tumor metabolism, allosteric modulators, ATP-competitive inhibitor, anti-neoplastic strategie
570, Allosteric inhibitor, Anti-neoplastic strategie, chaperone proteins, Chaperone, Settore BIOS-07/A - Biochimica, TRAP1, chaperone, chaperones, HSP90, Tumor metabolism, RC254-282, Mitochondria; Tumor metabolism, allosteric inhibitor, HSP90 family, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, neoplastic progression, Mitochondria, mitochondria, Oncology, ATP-competitive inhibitors; HSP90; TRAP1; Allosteric inhibitor; Anti-neoplastic strategies; Chaperones;, tumor metabolism, allosteric modulators, ATP-competitive inhibitor, anti-neoplastic strategie
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 35 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
